2016 Volume No 32
pages 241-256
Title: Optimisation of BMP-2 dosage for the osseointegration of porous titanium implants in an ovine model |
Authors: EB Hunziker, J Jovanovic, A Horner, MJB Keel, K Lippuner, N Shintani |
Address: Departments of Osteoporosis and Orthopaedic Surgery, Inselspital (DKF), University of Bern, Murtenstrasse 35, 3008 Bern, Switzerland |
E-mail: nahoko.shintani at dkf.unibe.ch |
Key Words: Porous titanium implants, locally-contained BMP-2, dosage optimisation, slow-release delivery system, osteoinduction, osseointegration. |
Publication date: November 18th 2016 |
Abstract: In clinical orthopaedics, total joint replacements and spinal fusions are routine undertakings. Many of the implicated patients suffer from osteoporosis, severe arthrosis or osteopaenia. In individuals thus afflicted, the bony bed lacks the mechanical stability that is a requisite for a firm anchorage of the implant and its functional competence. To promote the bony bondage of an implant it is necessary to induce neo-ossification by the introduction of an osteogenic agent, such as bone morphogenetic protein 2 (BMP-2). Since this growth factor is generally applied in a free form and at high dosages to maximise its osteogenicity, untoward side effects frequently ensue. |
Article download: Pages
241-256 (PDF file) |